Some angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) can help decrease proteinuria, 40 and treatment with an ARB has resulted in a 23% reduction in the risk ...

GLP-1RAs were associated with significant reductions in mean blood glucose and weight compared with controls. The use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) appears to be beneficial ...

The use of SGLT2 inhibitors, especially dapagliflozin, can lower adiposopathy parameters in patients with CKD, regardless of ...

The REMODEL study clarified which pathways are responsible for semaglutide’s cardiorenal effects in patients with CKD and type 2 diabetes. Glucagon-like peptide-1 receptor agonists (GLP1-RA) are a ...

Please provide your email address to receive an email when new articles are posted on . Researchers evaluated four increasingly stringent eGFR-based algorithms for patients with CKD. The results could ...

Please provide your email address to receive an email when new articles are posted on . Patients with type 2 diabetes on empagliflozin were significantly less likely to experience a rapid decline in ...

Misdiagnosis of Latent Autoimmune Diabetes of Adulthood GLP-1RAs were associated with significant reductions in mean blood glucose and weight compared with controls. GLP-1RAs were associated with ...